BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 28110021)

  • 1. The application of CRISPR technology to high content screening in primary neurons.
    Callif BL; Maunze B; Krueger NL; Simpson MT; Blackmore MG
    Mol Cell Neurosci; 2017 Apr; 80():170-179. PubMed ID: 28110021
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genome modification by CRISPR/Cas9.
    Ma Y; Zhang L; Huang X
    FEBS J; 2014 Dec; 281(23):5186-93. PubMed ID: 25315507
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transcriptional repression of PTEN in neural cells using CRISPR/dCas9 epigenetic editing.
    Moses C; Hodgetts SI; Nugent F; Ben-Ary G; Park KK; Blancafort P; Harvey AR
    Sci Rep; 2020 Jul; 10(1):11393. PubMed ID: 32647121
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combination of the clustered regularly interspaced short palindromic repeats (CRISPR)-associated 9 technique with the piggybac transposon system for mouse in utero electroporation to study cortical development.
    Cheng M; Jin X; Mu L; Wang F; Li W; Zhong X; Liu X; Shen W; Liu Y; Zhou Y
    J Neurosci Res; 2016 Sep; 94(9):814-24. PubMed ID: 27317429
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunocytochemistry and fluorescence imaging efficiently identify individual neurons with CRISPR/Cas9-mediated gene disruption in primary cortical cultures.
    Tsunematsu H; Uyeda A; Yamamoto N; Sugo N
    BMC Neurosci; 2017 Aug; 18(1):55. PubMed ID: 28764650
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Bacterial Enzyme Cas13 Interferes with Neurite Outgrowth from Cultured Cortical Neurons.
    Wu QW; Kapfhammer JP
    Toxins (Basel); 2021 Apr; 13(4):. PubMed ID: 33916905
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CRISPR/Cas9 mediated generation of stable chondrocyte cell lines with targeted gene knockouts; analysis of an aggrecan knockout cell line.
    Yang M; Zhang L; Stevens J; Gibson G
    Bone; 2014 Dec; 69():118-25. PubMed ID: 25260929
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-throughput screens in mammalian cells using the CRISPR-Cas9 system.
    Peng J; Zhou Y; Zhu S; Wei W
    FEBS J; 2015 Jun; 282(11):2089-96. PubMed ID: 25731961
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The MicroRNA-17-92 cluster enhances axonal outgrowth in embryonic cortical neurons.
    Zhang Y; Ueno Y; Liu XS; Buller B; Wang X; Chopp M; Zhang ZG
    J Neurosci; 2013 Apr; 33(16):6885-94. PubMed ID: 23595747
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genome-wide CRISPR knockout screens identify ADAMTSL3 and PTEN genes as suppressors of HCC proliferation and metastasis, respectively.
    Zhou X; Li R; Jing R; Zuo B; Zheng Q
    J Cancer Res Clin Oncol; 2020 Jun; 146(6):1509-1521. PubMed ID: 32266537
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Perspective on the Future of High-Throughput RNAi Screening: Will CRISPR Cut Out the Competition or Can RNAi Help Guide the Way?
    Taylor J; Woodcock S
    J Biomol Screen; 2015 Sep; 20(8):1040-51. PubMed ID: 26048892
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dramatic Improvement of CRISPR/Cas9 Editing in
    Ng H; Dean N
    mSphere; 2017; 2(2):. PubMed ID: 28435892
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Harnessing CRISPR-Cas systems for bacterial genome editing.
    Selle K; Barrangou R
    Trends Microbiol; 2015 Apr; 23(4):225-32. PubMed ID: 25698413
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Advances in therapeutic CRISPR/Cas9 genome editing.
    Savić N; Schwank G
    Transl Res; 2016 Feb; 168():15-21. PubMed ID: 26470680
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CRISPR-Cas9 for medical genetic screens: applications and future perspectives.
    Xue HY; Ji LJ; Gao AM; Liu P; He JD; Lu XJ
    J Med Genet; 2016 Feb; 53(2):91-7. PubMed ID: 26673779
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Generation and characterization of a human oral squamous carcinoma cell line SCC-9 with CRISPR/Cas9-mediated deletion of the p75 neurotrophin receptor.
    Huang P; Tong D; Sun J; Li Q; Zhang F
    Arch Oral Biol; 2017 Oct; 82():223-232. PubMed ID: 28654784
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CRISPR mediated somatic cell genome engineering in the chicken.
    Véron N; Qu Z; Kipen PA; Hirst CE; Marcelle C
    Dev Biol; 2015 Nov; 407(1):68-74. PubMed ID: 26277216
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bacterial CRISPR/Cas DNA endonucleases: A revolutionary technology that could dramatically impact viral research and treatment.
    Kennedy EM; Cullen BR
    Virology; 2015 May; 479-480():213-20. PubMed ID: 25759096
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Generation of PTEN‑knockout (‑/‑) murine prostate cancer cells using the CRISPR/Cas9 system and comprehensive gene expression profiling.
    Takao A; Yoshikawa K; Karnan S; Ota A; Uemura H; De Velasco MA; Kura Y; Suzuki S; Ueda R; Nishino T; Hosokawa Y
    Oncol Rep; 2018 Nov; 40(5):2455-2466. PubMed ID: 30226608
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disruption of E3 ligase NEDD4 in peripheral neurons interrupts axon outgrowth: Linkage to PTEN.
    Christie KJ; Martinez JA; Zochodne DW
    Mol Cell Neurosci; 2012 Jun; 50(2):179-92. PubMed ID: 22561198
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.